4//SEC Filing
Graboyes Marc H 4
Accession 0001127602-10-006162
CIK 0001097264other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:09 PM ET
Size
10.9 KB
Accession
0001127602-10-006162
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Award
Common Stock
2010-02-22+41,617→ 61,677 total - Sale
Common Stock
2010-02-24$7.44/sh−2,349$17,477→ 57,912 total - Sale
Common Stock
2010-02-23$7.51/sh−1,416$10,634→ 60,261 total - Award
Stock Options (Right to Buy)
2010-02-22$7.56/sh+73,083$552,507→ 73,083 totalExercise: $7.56From: 2011-02-22Exp: 2020-02-22→ Common Stock (73,083 underlying)
Footnotes (3)
- [F1]Represents shares of common stock subject to restricted stock units ("RSUs") awarded under the Company's 2008 Equity Incentive Plan (the "Plan"). The RSUs vest in a series of four (4) successive equal annual installments over the four (4)-year period measured from the Vesting Commencement Date, subject to Participant's Continuous Service through each such date.
- [F2]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Graboyes sold a portion of his holdings for tax and estate planning purposes.
- [F3]Stock options vest according to the following schedule: Twelve forty-eighths (12/48) of the total number of shares subject to this option shall vest twelve (12) months after the vesting commencement date and an additional one forty-eighths (1/48) of the total number of shares subject to the option become exercisable each one-month-period thereafter, until all such shares are exercisable.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001305811
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:09 PM ET
- Size
- 10.9 KB